BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28624492)

  • 1. Cortical function and corticomotoneuronal adaptation in monomelic amyotrophy.
    Matamala JM; Geevasinga N; Huynh W; Dharmadasa T; Howells J; Simon NG; Menon P; Vucic S; Kiernan MC
    Clin Neurophysiol; 2017 Aug; 128(8):1488-1495. PubMed ID: 28624492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticomotoneuronal integrity and adaptation in spinal muscular atrophy.
    Farrar MA; Vucic S; Johnston HM; Kiernan MC
    Arch Neurol; 2012 Apr; 69(4):467-73. PubMed ID: 22491191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical hyperexcitability precedes lower motor neuron dysfunction in ALS.
    Menon P; Kiernan MC; Vucic S
    Clin Neurophysiol; 2015 Apr; 126(4):803-9. PubMed ID: 25227219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of racial background on motor cortical function as measured by threshold tracking transcranial magnetic stimulation.
    Suzuki YI; Ma Y; Shibuya K; Misawa S; Suichi T; Tsuneyama A; Nakamura K; Matamala JM; Dharmadasa T; Vucic S; Fan D; Kiernan MC; Kuwabara S
    J Neurophysiol; 2021 Sep; 126(3):840-844. PubMed ID: 34406906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical excitability testing distinguishes Kennedy's disease from amyotrophic lateral sclerosis.
    Vucic S; Kiernan MC
    Clin Neurophysiol; 2008 May; 119(5):1088-96. PubMed ID: 18313980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease.
    Vucic S; Kiernan MC
    Brain; 2006 Sep; 129(Pt 9):2436-46. PubMed ID: 16835248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of transcranial magnetic stimulation in delineating amyotrophic lateral sclerosis pathophysiology.
    Vucic S; Kiernan MC
    Handb Clin Neurol; 2013; 116():561-75. PubMed ID: 24112924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical excitability distinguishes ALS from mimic disorders.
    Vucic S; Cheah BC; Yiannikas C; Kiernan MC
    Clin Neurophysiol; 2011 Sep; 122(9):1860-6. PubMed ID: 21382747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical hyperexcitability and disease spread in amyotrophic lateral sclerosis.
    Menon P; Geevasinga N; van den Bos M; Yiannikas C; Kiernan MC; Vucic S
    Eur J Neurol; 2017 Jun; 24(6):816-824. PubMed ID: 28436181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inter-session reliability of short-interval intracortical inhibition measured by threshold tracking TMS.
    Matamala JM; Howells J; Dharmadasa T; Trinh T; Ma Y; Lera L; Vucic S; Burke D; Kiernan MC
    Neurosci Lett; 2018 May; 674():18-23. PubMed ID: 29501687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superconditioning TMS for examining upper motor neuron function in MND.
    Calancie B; Young E; Watson ML; Wang D; Alexeeva N
    Exp Brain Res; 2019 Aug; 237(8):2087-2103. PubMed ID: 31175383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse split hand syndrome: Dissociated intrinsic hand muscle atrophy pattern in Hirayama disease/brachial monomelic amyotrophy.
    Singh RJ; Preethish-Kumar V; Polavarapu K; Vengalil S; Prasad C; Nalini A
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):10-16. PubMed ID: 27575868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new parameter to discriminate amyotrophic lateral sclerosis patients from healthy participants by motor cortical excitability changes.
    Cengiz B; Kuruoğlu R
    Muscle Nerve; 2020 Mar; 61(3):354-362. PubMed ID: 31875983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights.
    Vucic S; Ziemann U; Eisen A; Hallett M; Kiernan MC
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1161-70. PubMed ID: 23264687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of sensory-motor integration at spinal level in amyotrophic lateral sclerosis.
    Sangari S; Iglesias C; El Mendili MM; Benali H; Pradat PF; Marchand-Pauvert V
    Clin Neurophysiol; 2016 Apr; 127(4):1968-77. PubMed ID: 26971478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical excitability differences between flexor pollicis longus and APB.
    Bae JS; Menon P; Mioshi E; Kiernan MC; Vucic S
    Neurosci Lett; 2013 Apr; 541():150-4. PubMed ID: 23499957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of human corticospinal excitability by paired associative stimulation in patients with amyotrophic lateral sclerosis and effects of Riluzole.
    Ceccanti M; Onesti E; Rubino A; Cambieri C; Tartaglia G; Miscioscia A; Frasca V; Inghilleri M
    Brain Stimul; 2018; 11(4):775-781. PubMed ID: 29459142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticomotoneuronal function and hyperexcitability in acquired neuromyotonia.
    Vucic S; Cheah BC; Yiannikas C; Vincent A; Kiernan MC
    Brain; 2010 Sep; 133(9):2727-33. PubMed ID: 20736187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of cortical excitability using threshold tracking techniques.
    Vucic S; Howells J; Trevillion L; Kiernan MC
    Muscle Nerve; 2006 Apr; 33(4):477-86. PubMed ID: 16315324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolution of motor cortical dysfunction in amyotrophic lateral sclerosis.
    Shibuya K; Simon NG; Geevasinga N; Menon P; Howells J; Park SB; Huynh W; Noto YI; Vucic S; Kiernan MC
    Clin Neurophysiol; 2017 Jun; 128(6):1075-1082. PubMed ID: 28400096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.